A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Condition(s) studied
Investigational drug(s) / intervention(s)
Tirzepatide: Administered SC
Antihyperglycemic medication: As prescribed
Study summary
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.
Eligibility
Primary outcome measure(s)
- Change From Baseline in Hemoglobin A1c (HbA1c) — Baseline, Week 104
HbA1c is the glycosylated fraction of hemoglobin A. HbA1c is measured primarily to identify average plasma glucose concentration over prolonged periods of time. Values represented under "Least Squares (LS) Mean" are model-based estimates (MBE). MBE was calculated using a mixed-model repeated measures (MMRM) for post-baseline measures: Variable = Baseline + Geographic Region + Age + Treatment\*Time. Variance-covariance structure (Actual Value) = Unstructured. Variance-Covariance structure (Change from Baseline) = Unstructured.
Trial sites (90)
| Facility | City | Region | Status |
|---|---|---|---|
| Cahaba Research - Trussville | Birmingham | Alabama | |
| San Fernando Valley Health Institute | Canoga Park | California | |
| Velocity Clinical Research, Huntington Park | Huntington Park | California | |
| Velocity Clinical Research, San Diego | La Mesa | California | |
| Clinical Trials Research | Lincoln | California | |
| Velocity Clinical Research, Westlake | Los Angeles | California | |
| Catalina Research Institute, LLC | Montclair | California | |
| Velocity Clinical Research, North Hollywood | North Hollywood | California | |
| Velocity Clinical Research, Panorama City | Panorama City | California | |
| Western University of Health Sciences | Pomona | California | |
| Velocity Clinical Research, Santa Ana | Santa Ana | California | |
| New England Research Associates, LLC | Bridgeport | Connecticut | |
| Excel Medical Clinical Trials | Boca Raton | Florida | |
| Alliance for Multispecialty Research, LLC | Coral Gables | Florida | |
| South Florida Clinical Research Institute | Margate | Florida | |
| Emory University School of Medicine- Grady Campus | Atlanta | Georgia | |
| Center for Advanced Research & Education | Gainesville | Georgia | |
| Qualmedica Research, LLC | Evansville | Indiana | |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | |
| Qualmedica Research | Bowling Green | Kentucky | |
| NECCR PrimaCare Research | Fall River | Massachusetts | |
| SKY Integrative Medical Center/SKYCRNG | Ridgeland | Mississippi | |
| StudyMetrix Research | City of Saint Peters | Missouri | |
| Clinvest Research LLC | Springfield | Missouri | |
| Research Foundation of SUNY - University of Buffalo | Buffalo | New York | |
| Lucas Research, Inc | Morehead City | North Carolina | |
| The Corvallis Clinic, P.C. | Corvallis | Oregon | |
| Clinical Research of Philadelphia | Philadelphia | Pennsylvania | |
| Preferred Primary Care Physicians | Uniontown | Pennsylvania | |
| Tribe Clinical Research, LLC | Greenville | South Carolina | |
| Velocity Clinical Research, Spartanburg | Spartanburg | South Carolina | |
| Dallas Diabetes Research Center | Dallas | Texas | |
| Centro de Investigaciones Metabólicas (CINME) | Ciudad Autónoma de Buenos Aire | Buenos Aires | |
| Instituto de Investigaciones Clínicas Mar del Plata | Mar del Plata | Buenos Aires | |
| Go Centro Medico San Nicolás | San Nicolás de los Arroyos | Buenos Aires | |
| CIAD Moron | Morón | Buenos Air | |
| Centro Médico Viamonte | Buenos Aires | Ciudad Aut | |
| Dr. M.B. Jones Inc. | Victoria | British Columbia | |
| Bluewater Clinical Research Group Inc. | Sarnia | Ontario | |
| Stouffville Medical Centre | Stouffville | Ontario |
+ 50 more sites — see the full list on the official registry below.
On this site
📄 Mounjaro (tirzepatide) drug profile →More Eli Lilly and Company trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05433584 on ClinicalTrials.gov ↗ ← All trials in the USA